Specialized Pro-Resolving Lipid Mediators in Neonatal Cardiovascular Physiology and Diseases
Cardiovascular disease remains a leading cause of mortality worldwide. Unresolved inflammation plays a critical role in cardiovascular diseases development. Specialized Pro-Resolving Mediators (SPMs), derived from long chain polyunsaturated fatty acids (LCPUFAs), enhances the host defense, by resolv...
Main Authors: | Andrea Gila-Diaz, Gloria Herranz Carrillo, Pratibha Singh, David Ramiro-Cortijo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/6/933 |
Similar Items
-
Development of an Optimized LC-MS Method for the Detection of Specialized Pro-Resolving Mediators in Biological Samples
by: Laura Kutzner, et al.
Published: (2019-03-01) -
Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
by: Oxana Kytikova, et al.
Published: (2019-06-01) -
Biosynthetic pathways of pro-resolving lipid mediators In vascular cells
by: Komshian, Sevan
Published: (2016) -
PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs)
by: Banzo, R.G, et al.
Published: (2022) -
Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response
by: Pedro-Antonio Regidor, et al.
Published: (2021-12-01)